Impact of Yoga on Spinal Mobility and Psychological Outcomes in Patients with Axial Spondyloarthritis: A Prospective Non-randomized Controlled Study. [PDF]
Bundle V +14 more
europepmc +1 more source
Feasibility and exploratory outcomes of a multimodal pulmonary rehabilitation program in radiographic axial spondyloarthritis: A prospective single-arm pilot study. [PDF]
Şahin N +3 more
europepmc +1 more source
Predicting ankylosing spondylitis disease activity via patient-reported outcome measures: Building prediction models based on machine learning. [PDF]
Gong Y, Liu A, Zhuo L, Xu X, Liu H.
europepmc +1 more source
Fat infiltration is moderately associated with disease activity in ankylosing spondylitis: a cross-sectional study: Lumbar paraspinal muscles in ankylosing spondylitis. [PDF]
Toprak M, Toprak N.
europepmc +1 more source
Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension. [PDF]
Navarro-Compán V +9 more
europepmc +1 more source
Maintained improvement in patient-reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction: findings from the randomised period of a phase 3b trial. [PDF]
Chan A +8 more
europepmc +1 more source
The Impact of Preoperative Inflammatory Activity in Patients with Ankylosing Spondylitis on Postoperative Joint Function: A Retrospective Cohort Study. [PDF]
Man SL +6 more
europepmc +1 more source
The CALLY Index May Reflect Systemic Inflammatory Burden Rather than Patient-Reported Disease Activity in Ankylosing Spondylitis: A Medical Record-Based Cross-Sectional Study. [PDF]
Güner A +3 more
europepmc +1 more source
Physical Activity, Guideline Compliance, and Exercise Preferences in Axial Spondyloarthritis: A Comparative Cross-Sectional Study. [PDF]
Demirulus S +3 more
europepmc +1 more source
No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials. [PDF]
Ramiro S +6 more
europepmc +1 more source

